Although gluten intake from non-food sources is unlikely to contribute significantly to gluten exposure and symptoms in the majority of patients with celiac disease, it should be considered in cases of persistently active disease or symptoms
Several clinical trials showed that doses of 3.75/23 mg (phentermine) and 15/92 mg (TPM) were more effective than the placebo over the course of 52 weeks, 56 weeks, and 108 weeks
Because Dihexa promotes structural changes in synaptic architecture rather than temporary neurotransmitter modulation, improvements often persist beyond the treatment period
Milani A, Basirnejad M, Shahbazi S, Bolhassani A
Maximierte GLP-1-Aktivierung Eine einzigartige Kombination aus prbiotischen, probiotischen und postbiotischen Inhaltsstoffen verstrkt und verlngert die GLP-1-Rezeptorantwort
Autophagy plays a dual role in tumor growth